View of The use of ischemia modified albumin as a predictive and prognostic biomarker in patients with non–acetaminophen-induced acute liver failure

Return to Article Details The use of ischemia modified albumin as a predictive and prognostic biomarker in patients with non–acetaminophen-induced acute liver failure Download Download PDF